CD8A and COVID-19: In a study involving 123 COVID-19 patients with lymphocytopenia, it was observed that the mild and the severe group showed a 28.43% and a 61.9% reduction in CD8+ T cell population, respectively; besides their corresponding 34.31% and 47.62% reduction in natural killer (NK) cell population (Fig. 2b)34.